Women's Health

New biomarker in breast and prostate cancer may help identify patients who will respond to taxanes

Researchers have pinpointed a novel genetic biomarker responsible for the progression of many breast and prostate cancers.

Researchers identify tumor microenvironment of metastasis (TMEM) that allows breast cancer to metastasize

Using high-resolution imaging, scientists have gained a greater understanding of how a doorway in the blood vessel wall allows cancer cells to metastasize.

Obesity may predispose breast tissue structure to cancer

Obesity may predispose breast tissue structure to cancer

Findings suggest obesity can trigger structural changes in extracellular matrix, rendering an individual more susceptible to breast cancer.

New contrast agent spotlights tiny tumors and micrometastases

Researchers have developed a magnetic resonance imaging (MRI) contrast agent with the capability to pinpoint much smaller aggressive breast cancer tumors and micrometastases.

Fertility concerns influence treatment decisions in younger patients with breast cancer

Fertility concerns influence treatment decisions in younger patients with breast cancer

Previous studies have shown that following a 5-year course of tamoxifen after breast cancer treatment can reduce recurrence.

Electroacupuncture may reduce hot flashes among breast cancer survivors

Electroacupuncture may reduce hot flashes among breast cancer survivors

Electroacupuncture may be more effective and safer than gabapentin for managing hot flashes among breast cancer survivors.

Beta-blockers may improve survival in epithelial ovarian cancer

Beta-blockers may improve survival in epithelial ovarian cancer

Beta-blockers, particularly first-generation nonselective beta-blockers, improved overall survival among patients with epithelial ovarian cancer.

Carboplatin plus paclitaxel improves quality of life in ovarian cancer

Carboplatin plus paclitaxel improves quality of life in ovarian cancer

There is no significant quality of life advantage of cisplatin plus topotecan in treatment of women with newly diagnosed ovarian cancer.

Incidence of endometrial cancer increasing across multiple racial groups

Incidence of endometrial cancer increasing across multiple racial groups

Non-Hispanic black women have higher endometrial cancer incidence and lower survival across all stages and subtypes.

For patients with DCIS, risk of death higher for women under 35, black women

For patients with DCIS, risk of death higher for women under 35, black women

Women diagnosed with ductal carcinoma in situ have a 20-year breast cancer-specific death rate of 3.3%.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs